Insights on the Active Pharmaceutical Ingredient Global Market to 2026 – Emergence of Biosimilars Market Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Active Pharmaceutical Ingredient Market (2021-2026) by Ingredient, Synthesis Type, Molecule Type, Product Type, Manufacturing Type, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.

The Global Active Pharmaceutical Ingredient Market is estimated to be USD 199.25 Bn in 2021 and is expected to reach USD 271.97 Bn by 2026, growing at a CAGR of 6.42%.

Key factors such as the increasing incidence of chronic diseases with a rising geriatric population have significantly increased the Global Active Pharmaceutical Ingredient (API) market. Similarly, the growing dependence on API formulation in developing nations with lower costs and the rising investments of the pharmaceutical companies in API drugs also benefit market growth. Moreover, the advancements in API manufacturing with improvements in the API synthesis process and the evolving biosimilars market is expected to create opportunities in the Global Active Pharmaceutical Ingredient Market.

However, the price control policies and high costs of manufacturing API drugs are restraining the market’s growth.

The Global Active Pharmaceutical Ingredient Market is segmented based on Ingredient, Synthesis Type, Molecule Type, Product Type, Manufacturing Type, And Geography.

Countries Studied

• America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
• Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
• Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
• Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Active Pharmaceutical Ingredient Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
• The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report also contains the competitive analysis using IGR Positioning Quadrants, Infogence’s Proprietary competitive positioning tool.

Market Dynamics

Drivers

• Increasing Incidence of Diseases
• Growing Baby Boomers and Millennials Medical Expenditure
• Growing Demand of API Formulation and Generics in Developing Countries

Restraints

• High Manufacturing Costs
• Regulatory Policies and Unfavourable Drug Price Control Policies

Opportunities

• Companies Investment in Development of New Drugs and Precision Medicine
• Growth In The Contract Manufacturing Organizations (CMOs)
• Emergence Of Biosimilars Market
• Growing Artificial Intelligence (AI) Adoption for Drug Discovery

Challenges

• Drug Price Control Policies Across Various Countries

Companies Mentioned

• AbbVie, Inc.
• Albemarle Corporation
• AstraZeneca plc
• Aurobindo Pharma Limited
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• Cipla, Inc.
• Dr. Reddy’s Laboratories Ltd
• Eli Lilly and Company
• Glaxosmithkline Plc
• Hoffmann-La Roche Ltd.
• Merck & Co., Inc.
• Novartis Ag
• Pfizer, Inc.
• Roche Holding AG
• Sanofi
• Shenzhen Hepalink Pharmaceutical Co., Ltd.
• Sun Pharmaceutical Industries Ltd.
• Teva Active Pharmaceutical Ingredients
• Viatris Inc
• Zhejiang Huahai Pharmaceutical Co., Ltd

For more information about this report visit https://www.researchandmarkets.com/r/2kak7

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900